CT and MR imaging of chemotherapy-induced hepatopathy
Autor: | Filippo Barbiera, Giuseppe Badalamenti, Marco Dioguardi Burgio, Massimo Midiri, Valérie Vilgrain, Silvestro Cusmà, Federica Vernuccio, Giuseppe Brancatelli |
---|---|
Přispěvatelé: | Vernuccio, Federica, Dioguardi Burgio, Marco, Barbiera, Filippo, Cusmà, Silvestro, Badalamenti, Giuseppe, Midiri, Massimo, Vilgrain, Valérie, Brancatelli, Giuseppe |
Rok vydání: | 2019 |
Předmět: |
medicine.medical_specialty
Urology medicine.medical_treatment 030218 nuclear medicine & medical imaging 03 medical and health sciences 0302 clinical medicine Fibrosis Internal medicine Parenchyma medicine Humans Radiology Nuclear Medicine and imaging Hepatitis Chemotherapy Radiological and Ultrasound Technology medicine.diagnostic_test Chemotherapy Hepatopathy Computed tomography Magnetic resonance imaging Sinusoidal obstruction syndrome business.industry Gastroenterology Magnetic resonance imaging Hepatology medicine.disease Mr imaging Magnetic Resonance Imaging 030220 oncology & carcinogenesis sense organs Radiology Steatosis Chemical and Drug Induced Liver Injury business Tomography X-Ray Computed |
Zdroj: | Abdominal radiology (New York). 44(10) |
ISSN: | 2366-0058 |
Popis: | Chemotherapy-induced hepatopathy includes a wide variety of parenchymal and vascular hepatic changes on imaging, including diffuse or focal hepatopathies (i.e. hepatitis, steatosis, fibrosis, pseudocirrhosis, or sinusoidal obstruction). These changes can profoundly alter the hepatic parenchyma on imaging and result in both false negative and false-positive diagnoses of hepatic metastases and lead to errors in patient management strategies. It is therefore important for radiologists to have a comprehensive knowledge of the imaging patterns that may develop following chemotherapy. The purpose of this review is to explore the broad spectrum of hepatic parenchymal and vascular chemotherapy-induced changes on CT and MR imaging. |
Databáze: | OpenAIRE |
Externí odkaz: |